
Medpace Holdings, Inc. – NASDAQ:MEDP
Medpace Holdings stock price today
Medpace Holdings stock price monthly change
Medpace Holdings stock price quarterly change
Medpace Holdings stock price yearly change
Medpace Holdings key metrics
Market Cap | 10.52B |
Enterprise value | 6.13B |
P/E | 26.2 |
EV/Sales | 4.20 |
EV/EBITDA | 13.84 |
Price/Sales | 4.09 |
Price/Book | 15.46 |
PEG ratio | 0.53 |
EPS | 10.16 |
Revenue | 1.96B |
EBITDA | 381.36M |
Income | 312.50M |
Revenue Q/Q | 17.73% |
Revenue Y/Y | 25.56% |
Profit margin | 16.81% |
Oper. margin | 19.09% |
Gross margin | 29.62% |
EBIT margin | 19.09% |
EBITDA margin | 19.43% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMedpace Holdings stock price history
Medpace Holdings stock forecast
Medpace Holdings financial statements
$369.67
Potential downside: -21.68%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 460.86M | 61.06M | 13.25% |
---|---|---|---|
Sep 2023 | 492.49M | 70.55M | 14.32% |
Dec 2023 | 498.40M | 78.29M | 15.71% |
Mar 2024 | 511.04M | 102.59M | 20.07% |
Jun 2023 | 1406938000 | 1.01B | 72.2% |
---|---|---|---|
Sep 2023 | 1486721000 | 1.01B | 68.33% |
Dec 2023 | 1656828000 | 1.09B | 66.26% |
Mar 2024 | 1795789000 | 1.12B | 62.6% |
Jun 2023 | 82.51M | -8.46M | -82.21M |
---|---|---|---|
Sep 2023 | 114.38M | -8.66M | -49.27M |
Dec 2023 | 156.39M | -7.99M | 1.52M |
Mar 2024 | 152.67M | 2.53M | 7.66M |
Medpace Holdings alternative data
Aug 2023 | 5,200 |
---|---|
Sep 2023 | 5,600 |
Oct 2023 | 5,600 |
Nov 2023 | 5,800 |
Dec 2023 | 5,800 |
Jan 2024 | 5,800 |
Feb 2024 | 5,800 |
Mar 2024 | 5,900 |
Apr 2024 | 5,900 |
May 2024 | 5,800 |
Jun 2024 | 5,800 |
Jul 2024 | 5,800 |
Medpace Holdings other data
Period | Buy | Sel |
---|---|---|
Sep 2023 | 0 | 636144 |
Nov 2023 | 0 | 601922 |
Dec 2023 | 0 | 60478 |
Feb 2024 | 0 | 958077 |
Mar 2024 | 0 | 783495 |
Apr 2024 | 0 | 16930 |
May 2024 | 0 | 135057 |
Jun 2024 | 0 | 7681 |
Aug 2024 | 0 | 3774 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | GEIGER JESSE J officer: President | Common Stock | 15,000 | $32.05 | $480,750 | ||
Option | GEIGER JESSE J officer: President | Employee Stock Option (Right to Buy) | 15,000 | $32.05 | $480,750 | ||
Option | BURWIG SUSAN E officer: Exec. VP.. | Common Stock | 7,500 | $32.05 | $240,375 | ||
Option | BURWIG SUSAN E officer: Exec. VP.. | Employee Stock Option (Right to Buy) | 7,500 | $32.05 | $240,375 | ||
Option | MCCARTHY CORNELIUS P. III director | Common Stock | 62 | N/A | N/A | ||
Option | MCCARTHY CORNELIUS P. III director | Restricted Stock Unit | 62 | N/A | N/A | ||
Option | KRAFT ROBERT O. director | Common Stock | 71 | N/A | N/A | ||
Option | KRAFT ROBERT O. director | Restricted Stock Unit | 71 | N/A | N/A | ||
Option | CARLEY BRIAN T director | Common Stock | 78 | N/A | N/A | ||
Option | CARLEY BRIAN T director | Restricted Stock Unit | 78 | N/A | N/A |
Quarter | Transcript |
---|---|
Q1 2024 23 Apr 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 13 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 24 Oct 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 25 Jul 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Dr. August James Troendle M.D. (1956) Chairman & Chief Executive Officer | $1,130,000 |
Ms. Susan E. Burwig (1963) Executive Vice President of Operations | $750,250 |
Mr. Jesse J. Geiger BBA, CPA (1974) Pres | $678,190 |
Mr. Stephen P. Ewald (1969) Chief Compliance Officer, Gen. Counsel & Corporation Sec. | $587,560 |
Medpace Holdings: It Might Be Time To Buy In
A Quest That Has Translated Into New Investments
MoneyShow's Best Investment Ideas For 2025: Part 6
Medpace: Clear Winner If China Blockade Succeeds
Medpace: Delivering Strong Results And Shareholder Returns
Medpace: A Great Anchor For A Long-Term Portfolio
Bruker's Q2 2023 Triumph: Dominates Scientific Instrument Market Again
Medpace: Resilience During The Down Cycle
Medpace: Gaining Market Share While Others Struggle
-
What's the price of Medpace Holdings stock today?
One share of Medpace Holdings stock can currently be purchased for approximately $472.
-
When is Medpace Holdings's next earnings date?
Unfortunately, Medpace Holdings's (MEDP) next earnings date is currently unknown.
-
Does Medpace Holdings pay dividends?
No, Medpace Holdings does not pay dividends.
-
How much money does Medpace Holdings make?
Medpace Holdings has a market capitalization of 10.52B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 29.17% to 1.89B US dollars.
-
What is Medpace Holdings's stock symbol?
Medpace Holdings, Inc. is traded on the NASDAQ under the ticker symbol "MEDP".
-
What is Medpace Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Medpace Holdings?
Shares of Medpace Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Medpace Holdings's key executives?
Medpace Holdings's management team includes the following people:
- Dr. August James Troendle M.D. Chairman & Chief Executive Officer(age: 69, pay: $1,130,000)
- Ms. Susan E. Burwig Executive Vice President of Operations(age: 62, pay: $750,250)
- Mr. Jesse J. Geiger BBA, CPA Pres(age: 51, pay: $678,190)
- Mr. Stephen P. Ewald Chief Compliance Officer, Gen. Counsel & Corporation Sec.(age: 56, pay: $587,560)
-
How many employees does Medpace Holdings have?
As Jul 2024, Medpace Holdings employs 5,800 workers, which is 2% less then previous quarter.
-
When Medpace Holdings went public?
Medpace Holdings, Inc. is publicly traded company for more then 9 years since IPO on 11 Aug 2016.
-
What is Medpace Holdings's official website?
The official website for Medpace Holdings is medpace.com.
-
Where are Medpace Holdings's headquarters?
Medpace Holdings is headquartered at 5375 Medpace Way, Cincinnati, OH.
-
How can i contact Medpace Holdings?
Medpace Holdings's mailing address is 5375 Medpace Way, Cincinnati, OH and company can be reached via phone at +51 35799911.
-
What is Medpace Holdings stock forecast & price target?
Based on 3 Wall Street analysts` predicted price targets for Medpace Holdings in the last 12 months, the avarage price target is $369.67. The average price target represents a -21.68% change from the last price of $472.
Medpace Holdings company profile:

Medpace Holdings, Inc.
medpace.comNASDAQ
5,900
Medical - Diagnostics & Research
Healthcare
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Cincinnati, OH 45227
CIK: 0001668397
ISIN: US58506Q1094
CUSIP: 58506Q109